drugset / Trial / NCT01513863

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

NCT01513863

Phase 1 Completed 602 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to demonstrate that metronidazole 1% topical gel is effective for the treatment of patients with moderate to severe rosacea.

Timeline

Start
2011-08
Primary completion
2012-06
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 1 % Topical

Indications